Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Jul-25 | Sell | Billy Neve | 95.00p | 3,170 | £3,011.50 |
30-Jul-25 | Exercise of option | Billy Neve | 0.000p | 6,666 | £0.00 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Jul-25 | Sell | Billy Neve | 95.00p | 3,170 | £3,011.50 |
30-Jul-25 | Exercise of option | Billy Neve | 0.000p | 6,666 | £0.00 |
Notifier | Holding | Value* |
---|---|---|
Darren Carter | 10,189,585 | £9,866,915 |
Steven Fine | 5,577,351 | £5,400,735 |
Billy Neve | 37,413 | £36,228 |
Richard Brearley | 30,000 | £29,050 |
Lucinda Riches | 21,929 | £21,235 |
Anna Maria Josephine Cavanagh Bentley | 21,104 | £20,436 |
Elizabeth Blythe | 4,385 | £4,246 |
Notifier** | Holding | Value* |
---|---|---|
Gresham House Asset Management Ltd | 8,093,809 | £7,837,505 |
JTC plc | 6,142,892 | £5,948,367 |
Iain Fraser Morgan | 4,206,689 | £4,073,477 |
Canaccord Genuity Wealth (International) Limited | 4,098,877 | £3,969,079 |
Schroder Investment Management Limited | 3,947,368 | £3,822,368 |
Allianz Global Investors (UK) Limited | 3,728,070 | £3,610,014 |
Alexander Carter | 3,652,355 | £3,536,697 |
Andrew Chapman | 3,652,355 | £3,536,697 |
Charles Hall | 3,652,355 | £3,536,697 |
Currency | UK Pounds |
Share Price | 96.83p |
Change Today | -0.17p |
% Change | -0.17 % |
52 Week High | 135.50 |
52 Week Low | 71.50 |
Volume | 26,302 |
Shares Issued | 122.81m |
Market Cap | £118.92m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | ||
Ex-Div | 16-Jun-22 | |
Paid | 15-Jul-22 | |
Amount | 3.10p |
Time | Volume / Share Price |
14:18 | 10,000 @ 97.38p |
14:14 | 3,577 @ 96.10p |
10:25 | 5,000 @ 96.10p |
10:25 | 588 @ 97.80p |
09:33 | 5,095 @ 97.90p |
CEO | Steven Fine |
Chair | Lucinda Riches |
CFO | Billy Neve |
You are here: research